New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 20, 2014
10:17 EDTISRIsoRay advances for second day after treatment used for pediatric cancer patient
Shares of IsoRay (ISR), which develops seed brachytherapy and medical radioisotope applications, are higher for a second straight session after the company announced yesterday that its technology had been used in the treatment of a pediatric patient's tumor. WHAT'S NOTABLE: IsoRay announced yesterday morning that a doctor in North Carolina had successfully completed the world's first pediatric implant using the company's Cesium-131 brachytherapy mesh. The patient was a 12 year old male who was diagnosed with recurrent metastatic Wilms tumor, which is a type of childhood kidney tumor. Radiation therapy was needed in this case to treat the surgical bed, according to the doctor, who added that designing the treatment mesh was done with the assistance of the IsoRay team and that the patient recovered normally and has been discharged home. PRICE ACTION: In morning trading today, IsoRay shares are up about 25% to $3.19. Shares had more than doubled yesterday following the company's announcement, adding $1.46, or 133.94%.
News For ISR From The Last 14 Days
Check below for free stories on ISR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 21, 2014
07:14 EDTISRAmerican Association of Physicists in Medicine to hold annual meeting
56th Annual Meeting of AAPM to be held in Austin, Texas on July 20-25.
July 16, 2014
08:32 EDTISRIsoRay coverage assumed with a Buy at Maxim
Price target raised to $5 from $3.50.
July 14, 2014
08:50 EDTISRIsoRay makes first Cesium-131 delivery for treatment of inoperable brain cancer
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use